aaiPharma Situation Underscores The Need for Due Diligence

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-05-02-2004, Volume 28, Issue 5

Sponsors who have been lax in performing financial due diligence on their contractors have been given a wake-up call by the recent developments at aaiPharma.

Related Content:

Bio/Pharma BusinessOutsourcingOutsourcing OutlookPharmaceutical Technology-05-02-2004
Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing
Avantor Sees Future of Opportunities with Growing Development of Next-Gen Biotherapeutics
Merck and Ginkgo Bioworks’ Collaboration to Improve Biologics Manufacturing Has Reached Its First Milestone